Toripalimab Combined With Definitive CCRT for LACC Patients

Abroad (travel likely)Recruiting

Conditions

Cervical Cancer · Chemoradiotherapy · Immunotherapy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ruijin Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Dan Ou) · od12341@rjh.com.cn · +8618801970632

Study leads

Haoping Xu
Principal Investigator
Ruijin Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

ASk Questions in GYnecologic Oncology (ASQ-GYO)

Ovarian Cancer · Endometrial Cancer · Cervical Cancer

Abroad (travel likely)Recruiting

Detroit, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Cervical Cancer · Cervix Cancer · Cervical Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Kampala, Uganda